HealthCor Management’s NEVRO CORP. NVRO Stock Holding History

HealthCor Management’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-67,600	Closed	-$3.15M	–	57
2022 Q3	$3.15M	Buy	+67,600	New	+$3.14M	0.39%	46
2022 Q1	–	Sell	-409,230	Closed	-$33.2M	–	74
2021 Q4	$33.2M	Sell	409,230 -120,000	-23%	-$12M	1.81%	21
2021 Q3	$61.6M	Buy	529,230 +152,900	+41%	+$20M	2.66%	12
2021 Q2	$62.4M	Buy	+376,330	New	+$58.7M	2.49%	16
2021 Q1	–	Sell	-156,046	Closed	-$27M	–	101
2020 Q4	$27M	Sell	156,046 -574,931	-79%	-$93.1M	1.04%	33
2020 Q3	$102M	Sell	730,977 -323,126	-31%	-$43.2M	4.08%	11
2020 Q2	$126M	Sell	1,054,103 -698,517	-40%	-$82.8M	5.28%	5
2020 Q1	$175M	Buy	1,752,620 +582,540	+50%	+$70.1M	7.49%	1
2019 Q4	$138M	Buy	1,170,080 +216,260	+23%	+$21.4M	4.91%	3
2019 Q3	$82M	Sell	953,820 -273,910	-22%	-$20.7M	3.1%	14
2019 Q2	$79.6M	Buy	1,227,730 +970,740	+378%	+$60.4M	3.09%	11
2019 Q1	$16.1M	Buy	256,990 +101,580	+65%	+$4.78M	0.65%	37
2018 Q4	$6.04M	Buy	+155,410	New	+$6.91M	0.19%	39
2016 Q2	–	Sell	-430,877	Closed	-$24.2M	–	51
2016 Q1	$24.2M	Buy	+430,877	New	+$25.4M	1.37%	22

Other funds holding NVRO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

HealthCor Management's NVRO Position: Q4 2022 in Review

HealthCor Management sold out of NEVRO CORP. (NVRO) in Q4 2022, closing a stake of 67,600 shares — an estimated $3.15M sold.

HealthCor Management first reported a position in NVRO in Q1 2016 and held it in 14 quarters. The position peaked at $175M in Q1 2020. 170 funds tracked by Wall St. Rank hold NVRO as of Q4 2022.

HealthCor Management reported no remaining NEVRO CORP. position as of Q4 2022 after selling out during the quarter.
HealthCor Management sold 67,600 NEVRO CORP. shares in Q4 2022, an estimated $3.15M.
HealthCor Management first reported a position in NEVRO CORP. in Q1 2016 and held it in 14 quarters.
HealthCor Management's NEVRO CORP. position peaked at $175M in Q1 2020.
170 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2022.

Based on HealthCor Management's 13F filing for Q4 2022, filed 15 Feb 2023.